BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 17192871)

  • 1. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
    Al-Ayyoubi S; Gali-Muhtasib H
    Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onopordum cynarocephalum induces apoptosis and protects against 1,2 dimethylhydrazine-induced colon cancer.
    El-Najjar N; Saliba N; Talhouk S; Gali-Muhtasib H
    Oncol Rep; 2007 Jun; 17(6):1517-23. PubMed ID: 17487413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo.
    Danbara N; Yuri T; Tsujita-Kyutoku M; Tsukamoto R; Uehara N; Tsubura A
    Anticancer Res; 2005; 25(3B):2269-76. PubMed ID: 16158974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
    Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
    Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.
    Manna S; Banerjee S; Mukherjee S; Das S; Panda CK
    Apoptosis; 2006 Dec; 11(12):2267-76. PubMed ID: 17041754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
    Shibata MA; Ito Y; Morimoto J; Otsuki Y
    Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
    Pidgeon GP; Kandouz M; Meram A; Honn KV
    Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical upregulation of tumor suppressor protein p53 in serum-stimulated vascular smooth muscle cells: a novel negative-feedback regulatory mechanism.
    Mnjoyan ZH; Dutta R; Zhang D; Teng BB; Fujise K
    Circulation; 2003 Jul; 108(4):464-71. PubMed ID: 12860918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
    Gupta S; Afaq F; Mukhtar H
    Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression.
    Liu W; Dai Q; Lu N; Wei L; Ha J; Rong J; Mu R; You Q; Li Z; Guo Q
    Biochem Cell Biol; 2011 Jun; 89(3):287-98. PubMed ID: 21491996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in breast cancer cells by TPA.
    Li Y; Bhuiyan M; Mohammad RM; Sarkar FH
    Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Tong WG; Ding XZ; Talamonti MS; Bell RH; Adrian TE
    Anticancer Drugs; 2007 Jun; 18(5):535-41. PubMed ID: 17414622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.